Pharmacists support generic substitution to save patients money, but face resistance from patients who distrust cheaper drugs, doctors who don't promote them, and complex rules around high-risk medications. Learn why this common practice sparks real concerns behind the counter.
Generic drugs make up 90% of U.S. prescriptions but many clinicians still lack confidence in them. Learn how better provider education improves prescribing, patient adherence, and healthcare costs.
Learn how to subscribe to FDA drug safety alerts for recalls, medication warnings, and urgent health advisories. Free, easy, and life-saving - here’s how to get alerts for the drugs you take.
Active ingredients treat your condition, but inactive ingredients determine if your medicine works properly - and whether you have side effects. Learn why the difference matters for safety, effectiveness, and personal health.
Learn how to accurately document provider advice about medications to prevent errors, improve care, and protect your health. Essential tips for patients on what to record, how to store it, and when to update.
Learn how mood stabilizers like lithium and antipsychotics like quetiapine manage bipolar disorder, their benefits, side effects, and how to navigate treatment safely. Real data, real experiences, and practical advice.
Beyond-use dates for compounded medications are science-based safety limits, not arbitrary labels. Learn how they differ from expiration dates, why they matter, and how to ensure your custom meds are safe to use.
Psychiatric medications can save lives, but dangerous combinations-like SSRIs with MAOIs or lithium with NSAIDs-can cause life-threatening reactions. Learn the risks, warning signs, and how to stay safe.
Chloromycetin (chloramphenicol) is rarely used today due to serious side effects. Discover safer, more effective antibiotic alternatives like ceftriaxone, azithromycin, and doxycycline for treating bacterial infections.
Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments in the U.S., encouraging development where profits are low. Learn how it works, who benefits, and why it's controversial.